SEARCH

SEARCH BY CITATION

References

  • 1
    Peltomaki P. Lynch syndrome genes. Fam Cancer 2005; 4: 22732.
  • 2
    Woods MO,Williams P,Careen A,Edwards L,Bartlett S,McLaughlin JR,Younghusband HB. A new variant database for mismatch repair genes associated with Lynch syndrome. Hum Mutat 2007; 28: 66973.
  • 3
    Peltomaki P,Vasen H. Mutations associated with HNPCC predisposition – update of ICG-HNPCC/INSiGHT mutation database. Dis Markers 2004; 20: 26976.
  • 4
    Ollikainen M,Hannelius U,Lindgren CM,Abdel-Rahman WM,Kere J,Peltomaki P. Mechanisms of inactivation of MLH1 in hereditary nonpolyposis colorectal carcinoma: a novel approach. Oncogene 2007; 26: 45419.
  • 5
    Jarvinen HJ,Aarnio M,Mustonen H,Aktan-Collan K,Aaltonen LA,Peltomaki P,De La Chapelle A,Mecklin JP. Controlled 15-year trial on screening for colorectal cancer in families with hereditary nonpolyposis colorectal cancer. Gastroenterology 2000; 118: 82934.
  • 6
    Vasen HF,Mecklin JP,Khan PM,Lynch HT. The international collaborative group on hereditary non-polyposis colorectal cancer (ICG-HNPCC). Dis Colon Rectum 1991; 34: 4245.
  • 7
    Nystrom-Lahti M,Wu Y,Moisio AL,Hofstra RM,Osinga J,Mecklin JP,Jarvinen HJ,Leisti J,Buys CH,de la Chapelle A,Peltomaki P. DNA mismatch repair gene mutations in 55 kindreds with verified or putative hereditary non-polyposis colorectal cancer. Hum Mol Genet 1996; 5: 7639.
  • 8
    Wijnen J,Khan PM,Vasen H,van der Klift H,Mulder A,van Leeuwen-Cornelisse I,Bakker B,Losekoot M,Moller P,Fodde R. Hereditary nonpolyposis colorectal cancer families not complying with the Amsterdam criteria show extremely low frequency of mismatch-repair-gene mutations. Am J Hum Genet 1997; 61: 32935.
  • 9
    Wagner A,Barrows A,Wijnen JT,van der Klift H,Franken PF,Verkuijlen P,Nakagawa H,Geugien M,Jaghmohan-Changur S,Breukel C,Meijers-Heijboer H,Morreau H, et al. Molecular analysis of hereditary nonpolyposis colorectal cancer in the united states: high mutation detection rate among clinically selected families and characterization of an American founder genomic deletion of the MSH2 gene. Am J Hum Genet 2003; 72: 1088100.
  • 10
    Umar A,Boland CR,Terdiman JP,Syngal S,de la Chapelle A,Ruschoff J,Fishel R,Lindor NM,Burgart LJ,Hamelin R,Hamilton SR,Hiatt RA, et al. Revised Bethesda guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability. J Natl Cancer Inst 2004; 96: 2618.
  • 11
    Pinol V,Castells A,Andreu M,Castellvi-Bel S,Alenda C,Llor X,Xicola RM,Rodriguez-Moranta F,Paya A,Jover R,Bessa X; Gastrointestinal Oncology Group of the Spanish Gastroenterological Association. Accuracy of revised Bethesda guidelines, microsatellite instability, and immunohistochemistry for the identification of patients with hereditary nonpolyposis colorectal cancer. JAMA 2005; 293: 198694.
  • 12
    Yan H,Papadopoulos N,Marra G,Perrera C,Jiricny J,Boland CR,Lynch HT,Chadwick RB,de la Chapelle A,Berg K,Eshleman JR,Yuan W, et al. Conversion of diploidy to haploidy. Nature 2000; 403: 7234.
  • 13
    Charbonnier F,Raux G,Wang Q,Drouot N,Cordier F,Limacher JM,Saurin JC,Puisieux A,Olschwang S,Frebourg T. Detection of exon deletions and duplications of the mismatch repair genes in hereditary nonpolyposis colorectal cancer families using multiplex polymerase chain reaction of short fluorescent fragments. Cancer Res 2000; 60: 27603.
  • 14
    Gille JJ,Hogervorst FB,Pals G,Wijnen JT,van Schooten RJ,Dommering CJ,Meijer GA,Craanen ME,Nederlof PM,de Jong D,McElgunn CJ,Schouten JP, et al. Genomic deletions of MSH2 and MLH1 in colorectal cancer families detected by a novel mutation detection approach. Br J Cancer 2002; 87: 8927.
  • 15
    Wijnen J,van der Klift H,Vasen H,Khan PM,Menko F,Tops C,Meijers Heijboer H,Lindhout D,Moller P,Fodde R. MSH2 genomic deletions are a frequent cause of HNPCC. Nat Genet 1998; 20: 3268.
  • 16
    Suter CM,Martin DI,Ward RL. Germline epimutation of MLH1 in individuals with multiple cancers. Nat Genet 2004; 36: 497501.
  • 17
    Chan TL,Yuen ST,Kong CK,Chan YW,Chan AS,Ng WF,Tsui WY,Lo MW,Tam WY,Li VS,Leung SY. Heritable germline epimutation of MSH2 in a family with hereditary nonpolyposis colorectal cancer. Nat Genet 2006; 38: 117883.
  • 18
    Mecklin JP,Jarvinen HJ,Aukee S,Elomaa I,Karjalainen K. Screening for colorectal carcinoma in cancer family syndrome kindreds. Scand J Gastroenterol 1987; 22: 44953.
  • 19
    Holmberg M,Kristo P,Chadwicks RB,Mecklin JP,Jarvinen H,de la Chapelle A,Nystrom-Lahti M,Peltomaki P. Mutation sharing, predominant involvement of the MLH1 gene and description of four novel mutations in hereditary nonpolyposis colorectal cancer. Mutations in brief No. 144. online. Hum Mutat 1998; 11: 482.
  • 20
    Renkonen E,Zhang Y,Lohi H,Salovaara R,Abdel-Rahman WM,Nilbert M,Aittomaki K,Jarvinen HJ,Mecklin JP,Lindblom A,Peltomaki P. Altered expression of MLH1, MSH2, and. MSH6 in predisposition to hereditary nonpolyposis colorectal cancer. J Clin Oncol 2003; 21: 362937.
  • 21
    Nystrom-Lahti M,Kristo P,Nicolaides NC,Chang SY,Aaltonen LA,Moisio AL,Jarvinen HJ,Mecklin JP,Kinzler KW,Vogelstein B. Founding mutations and Alu-mediated recombination in hereditary colon cancer. Nat Med 1995; 1: 12036.
  • 22
    Vasen HF,Watson P,Mecklin JP,Lynch HT. New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the International collaborative Group on HNPCC. Gastroenterology 1999; 116: 14536.
  • 23
    Lahiri DK,Nurnberger JI,Jr. A rapid non-enzymatic method for the preparation of HMW DNA from blood for RFLP studies. Nucleic Acids Res 1991; 19: 5444.
  • 24
    Isola J,DeVries S,Chu L,Ghazvini S,Waldman F. Analysis of changes in DNA sequence copy number by comparative genomic hybridization in archival paraffin-embedded tumor samples. Am J Pathol 1994; 145: 13018.
  • 25
    Boland CR,Thibodeau SN,Hamilton SR,Sidransky D,Eshleman JR,Burt RW,Meltzer SJ,Rodriguez-Bigas MA,Fodde R,Ranzani GN,Srivastava S. A national cancer institute workshop on microsatellite instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer. Cancer Res 1998; 58: 524857.
  • 26
    Loukola A,Eklin K,Laiho P,Salovaara R,Kristo P,Jarvinen H,Mecklin JP,Launonen V,Aaltonen LA. Microsatellite marker analysis in screening for hereditary nonpolyposis colorectal cancer (HNPCC). Cancer Res 2001; 61: 45459.
  • 27
    Halvarsson B,Lindblom A,Rambech E,Lagerstedt K,Nilbert M. Microsatellite instability analysis and/or immunostaining for the diagnosis of hereditary nonpolyposis colorectal cancer? Virchows Arch 2004; 444: 13541.
  • 28
    Schouten JP,McElgunn CJ,Waaijer R,Zwijnenburg D,Diepvens F,Pals G. Relative quantification of 40 nucleic acid sequences by multiplex ligation-dependent probe amplification. Nucleic Acids Res 2002; 30: e57.
  • 29
    Joensuu EI,Abdel-Rahman WM,Ollikainen M,Ruosaari S,Knuutila S,Peltomaki P. Epigenetic signatures of familial cancer are characteristic of tumor type and family category. Cancer Res 2008; 68: 4597605.
  • 30
    Gylling A,Abdel-Rahman WM,Juhola M,Nuorva K,Hautala E,Jarvinen HJ,Mecklin JP,Aarnio M,Peltomaki P. Is gastric cancer part of the tumour spectrum of hereditary non-polyposis colorectal cancer? A molecular genetic study. Gut 2007; 56: 92633.
  • 31
    Kim YH,Petko Z,Dzieciatkowski S,Lin L,Ghiassi M,Stain S,Chapman WC,Washington MK,Willis J,Markowitz SD,Grady WM. CpG island methylation of genes accumulates during the adenoma progression step of the multistep pathogenesis of colorectal cancer. Genes Chromosomes Cancer 2006; 45: 7819.
  • 32
    Baudhuin LM,Ferber MJ,Winters JL,Steenblock KJ,Swanson RL,French AJ,Butz ML,Thibodeau SN. Characterization of hMLH1 and hMSH2 gene dosage alterations in Lynch syndrome patients. Gastroenterology 2005; 129: 84654.
  • 33
    Grabowski M,Mueller-Koch Y,Grasbon-Frodl E,Koehler U,Keller G,Vogelsang H,Dietmaier W,Kopp R,Siebers U,Schmitt W,Neitzel B,Gruber M, et al. Deletions account for 17% of pathogenic germline alterations in MLH1 and MSH2 in hereditary nonpolyposis colorectal cancer (HNPCC) families. Genet Test 2005; 9: 13846.
  • 34
    Pistorius S,Gorgens H,Plaschke J,Hoehl R,Kruger S,Engel C,Saeger HD,Schackert HK. Genomic rearrangements in MSH2, MLH1 or MSH6 are rare in HNPCC patients carrying point mutations. Cancer Lett 2007; 248: 8995.
  • 35
    Chan TL,Yuen ST,Ho JW,Chan AS,Kwan K,Chung LP,Lam PW,Tse CW,Leung SY. A novel germline 1.8-kb deletion of hMLH1 mimicking alternative splicing: a founder mutation in the Chinese population. Oncogene 2001; 20: 297681.
  • 36
    Li L,McVety S,Younan R,Liang P,Du Sart D,Gordon PH,Hutter P,Hogervorst FB,Chong G,Foulkes WD. Distinct patterns of germ-line deletions in MLH1 and MSH2: the implication of Alu repetitive element in the genetic etiology of Lynch syndrome (HNPCC). Hum Mutat 2006; 27: 388.
  • 37
    van der Klift H,Wijnen J,Wagner A,Verkuilen P,Tops C,Otway R,Kohonen-Corish M,Vasen H,Oliani C,Barana D,Moller P,Delozier-Blanchet C, et al. Molecular characterization of the spectrum of genomic deletions in the mismatch repair genes MSH2, MLH1, MSH6, and PMS2 responsible for hereditary nonpolyposis colorectal cancer (HNPCC). Genes Chromosomes Cancer 2005; 44: 12338.
  • 38
    Gazzoli I,Loda M,Garber J,Syngal S,Kolodner RD. A hereditary nonpolyposis colorectal carcinoma case associated with hypermethylation of the MLH1 gene in normal tissue and loss of heterozygosity of the unmethylated allele in the resulting microsatellite instability-high tumor. Cancer Res 2002; 62: 39258.
  • 39
    Miyakura Y,Sugano K,Akasu T,Yoshida T,Maekawa M,Saitoh S,Sasaki H,Nomizu T,Konishi F,Fujita S,Moriya Y,Nagai H. Extensive but hemiallelic methylation of the hMLH1 promoter region in early-onset sporadic colon cancers with microsatellite instability. Clin Gastroenterol Hepatol 2004; 2: 14756.
  • 40
    Hitchins MP,Wong JJ,Suthers G,Suter CM,Martin DI,Hawkins NJ,Ward RL. Inheritance of a cancer-associated MLH1 germ-line epimutation. N Engl J Med 2007; 356: 697705.
  • 41
    Valle L,Carbonell P,Fernandez V,Dotor AM,Sanz M,Benitez J,Urioste M. MLH1 germline epimutations in selected patients with early-onset non-polyposis colorectal cancer. Clin Genet 2007; 71: 2327.
  • 42
    Morak M,Schackert HK,Rahner N,Betz B,Ebert M,Walldorf C,Royer-Pokora B,Schulmann K,von Knebel-Doeberitz M,Dietmaier W,Keller G,Kerker B, et al. Further evidence for heritability of an epimutation in one of 12 cases with MLH1 promoter methylation in blood cells clinically displaying HNPCC. Eur J Hum Genet 2008; 16: 80411.
  • 43
    Hitchins M,Williams R,Cheong K,Halani N,Lin VA,Packham D,Ku S,Buckle A,Hawkins N,Burn J,Gallinger S,Goldblatt J, et al. MLH1 germline epimutations as a factor in hereditary nonpolyposis colorectal cancer. Gastroenterology 2005; 129: 13929.
  • 44
    Wagner A,van der Klift H,Franken P,Wijnen J,Breukel C,Bezrookove V,Smits R,Kinarsky Y,Barrows A,Franklin B,Lynch J,Lynch H, et al. A 10-mb paracentric inversion of chromosome arm 2p inactivates MSH2 and is responsible for hereditary nonpolyposis colorectal cancer in a North-American kindred. Genes Chromosomes Cancer 2002; 35: 4957.
  • 45
    Shin KH,Shin JH,Kim JH,Park JG. Mutational analysis of promoters of mismatch repair genes hMSH2 and hMLH1 in hereditary nonpolyposis colorectal cancer and early onset colorectal cancer patients: identification of three novel germ-line mutations in promoter of the hMSH2 gene. Cancer Res 2002; 62: 3842.
  • 46
    Clendenning M,Senter L,Hampel H,Robinson KL,Sun S,Buchanan D,Walsh MD,Nilbert M,Green J,Potter J,Lindblom A,de la Chapelle A. A frame-shift mutation of PMS2 is a widespread cause of Lynch syndrome. J Med Genet 2008; 45: 3405.
  • 47
    Chang DK,Ricciardiello L,Goel A,Chang CL,Boland CR. Steady-state regulation of the human DNA mismatch repair system. J Biol Chem 2000; 275: 1842431.